Zelcer Noam, Reid Glen, Wielinga Peter, Kuil Annemieke, van der Heijden Ingrid, Schuetz John D, Borst Piet
Division of Molecular Biology and Center for Biomedical Genetics, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.
Biochem J. 2003 Apr 15;371(Pt 2):361-7. doi: 10.1042/BJ20021886.
Human multidrug-resistance protein (MRP) 4 transports cyclic nucleotides and when overproduced in mammalian cells mediates resistance to some nucleoside analogues. Recently, it has been shown that Mrp4 is induced in the livers of Fxr ((-/-)) mice, which have increased levels of serum bile acids. Since MRP4, like MRP1-3, also mediates transport of a model steroid conjugate substrate, oestradiol 17-beta-D-glucuronide (E(2)17betaG), we tested whether MRP4 may be involved in the transport of steroid and bile acid conjugates. Bile salts, especially sulphated derivatives, and cholestatic oestrogens inhibited the MRP4-mediated transport of E(2)17betaG. Inhibition by oestradiol 3,17-disulphate and taurolithocholate 3-sulphate was competitive, suggesting that these compounds are MRP4 substrates. Furthermore, we found that MRP4 transports dehydroepiandrosterone 3-sulphate (DHEAS), the most abundant circulating steroid in humans, which is made in the adrenal gland. The ATP-dependent transport of DHEAS by MRP4 showed saturable kinetics with K (m) and V (max) values of 2 microM and 45 pmol/mg per min, respectively (at 27 degrees C). We further studied the possible involvement of other members of the MRP family of transporters in the transport of DHEAS. We found that MRP1 transports DHEAS in a glutathione-dependent manner and exhibits K (m) and V (max) values of 5 microM and 73 pmol/mg per min, respectively (at 27 degrees C). No transport of DHEAS was observed in membrane vesicles containing MRP2 or MRP3. Our findings suggest a physiological role for MRP1 and MRP4 in DHEAS transport and an involvement of MRP4 in transport of conjugated steroids and bile acids.
人类多药耐药蛋白(MRP)4可转运环核苷酸,在哺乳动物细胞中过量表达时可介导对某些核苷类似物的耐药性。最近研究表明,在血清胆汁酸水平升高的法尼醇X受体(Fxr)基因敲除(-/-)小鼠肝脏中,Mrp4被诱导表达。由于MRP4与MRP1 - 3一样,也介导一种模型类固醇结合物底物——雌二醇17-β-D-葡萄糖醛酸苷(E(2)17βG)的转运,因此我们测试了MRP4是否参与类固醇和胆汁酸结合物的转运。胆盐,尤其是硫酸化衍生物和胆汁淤积性雌激素,可抑制MRP4介导的E(2)17βG转运。3,17 - 二硫酸雌二醇和牛磺石胆酸3 - 硫酸盐的抑制作用具有竞争性,表明这些化合物是MRP4的底物。此外,我们发现MRP4可转运脱氢表雄酮3 - 硫酸盐(DHEAS),它是人体中最丰富的循环类固醇,由肾上腺产生。MRP4对DHEAS的ATP依赖性转运表现出饱和动力学,在27℃时,米氏常数(K (m))和最大反应速度(V (max))分别为2微摩尔和45皮摩尔/毫克每分钟。我们进一步研究了MRP转运蛋白家族的其他成员在DHEAS转运中的可能作用。我们发现MRP1以谷胱甘肽依赖性方式转运DHEAS,在27℃时,K (m)和V (max)值分别为5微摩尔和73皮摩尔/毫克每分钟。在含有MRP2或MRP3的膜囊泡中未观察到DHEAS的转运。我们的研究结果表明MRP1和MRP4在DHEAS转运中具有生理作用,并且MRP4参与结合类固醇和胆汁酸的转运。